- ►nevada.edu [PDF] CF Thomas Jr, AH Limper - The New England journal of medicine, 2004 - nejm.org Pneumocystis pneumonia remains the most prevalent opportunistic infection in patients infected
with the human immunodeficiency virus (HIV). 1 , 2 First identified as a protozoan nearly 100
years ago and reclassified as a fungus in 1988, pneumocystis cannot be propagated in ... Cited by 216 - Related articles - BL Direct - All 12 versions
SJ Skerrett - Clinics in chest medicine, 1999 - Elsevier The clinical, radiographic, and routine laboratory features of community-acquired pneumonia
(CAP) can offer clues to the microbial cause of the infection, but a specific etiologic diagnosis
requires the assistance of the microbiology laboratory. 143 Whether or not diagnostic ... Cited by 98 - Related articles - BL Direct - All 4 versions
AN Leung, MV Gosselin, CH Napper, SG Braun, WW … - Radiology, 1999 - radiology.rsna.org RESULTS: Cytomegalovirus and Aspergillus species were the two most common
pathogens, accounting for 22 and 17 episodes, respectively. During the first 30 days after bone
marrow transplantation, fungi caused the majority (nine [82%] of 11 episodes) of ... Cited by 96 - Related articles - BL Direct - All 4 versions
M Falguera, O Sacristan, A Nogues, A Ruiz- … - Archives of Internal …, 2001 - Am Med Assoc Methods During a 3-year period, all patients with nonsevere community-acquired
pneumonia, according to the Pneumonia Patient Outcome Research Team prognostic classification
(patients in groups 1-3), were included in the study. Causes were investigated through ... Cited by 94 - Related articles - BL Direct - All 5 versions
LG Reimer, KC Carroll - Clinical Infectious Diseases, 1998 - UChicago Press The appropriate use of the clinical microbiology laboratory for diagnosing lower respiratory tract
infections is controversial. As in clinical care, it is crucial to categorize the presenting illness properly
as acute bronchitis, an acute exacerbation of chronic bronchitis, community-acquired ... Cited by 79 - Related articles - BL Direct - All 5 versions
D Rimland, TR Navin, JL Lennox, JA Jernigan, J … - AIDS, 2002 - journals.lww.com From the a Veterans Affairs Medical Center and Research Center on AIDS and HIV Infection,
b Department of Medicine, Emory University School of Medicine, c Division of Parasitic
Diseases, National Center for Infectious Diseases, Centers for Disease Control and ... Cited by 49 - Related articles - BL Direct - All 6 versions
SK Gupta, GA Sarosi - Medical Clinics of North America, 2001 - Elsevier Legionella, M. pneumoniae, and C. pneumoniae do not respond to β-lactam antibiotics. They
do respond to macrolides, tetracyclines, and fluoroquinolones, however, prompting the debate
as to when to include these antibiotics in the empiric regimen for CAP. Using this ... Cited by 47 - Related articles - BL Direct - All 4 versions
N Rabella, P Rodriguez, R Labeaga, M … - Clinical Infectious …, 1999 - UChicago Press Page 1. 1043 Conventional Respiratory Viruses Recovered from Immunocompromised
Patients: Clinical Considerations N. Rabella, P. Rodriguez, R. Labeaga, M. Otegui,
From Servei de Microbiologia, Unitat de Malalties Infeccioses ... Cited by 43 - Related articles - BL Direct - All 4 versions
- ►bmj.com C Mayaud, J Cadranel - British Medical Journal, 2000 - thorax.bmj.com The diagnostic and therapeutic approach to respiratory disease in the immunocompromised
host remains a challenge for several reasons: (1) the current increase in both the number of immunocompromised
hosts and their length of survival; (2) the high frequency of lung disease in these patients, ... Cited by 46 - Related articles - BL Direct - All 5 versions
